Monthly Archives: August 2020
Exicure (XCUR) Receives a Rating Update from a Top Analyst
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Exicure (XCUR – Research Report) today and set a price target of $8.00. The company’s shares closed last Wednesday at $2.30. According to TipRanks.com, Selvaraju is a top 100 analyst
Analysts Offer Insights on Healthcare Companies: Viela Bio (NASDAQ: VIE) and Galectin Therapeutics (NASDAQ: GALT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viela Bio (VIE – Research Report) and Galectin Therapeutics (GALT – Research Report) with bullish sentiments. Viela Bio (VIE) H.C. Wainwright analyst
Misonix (MSON) Receives a Buy from Canaccord Genuity
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Misonix (MSON – Research Report), with a price target of $22.00. The company’s shares closed last Wednesday at $14.27. According to TipRanks.com, Rose is a
SI-Bone (SIBN) Receives a Buy from Canaccord Genuity
Canaccord Genuity analyst Kyle Rose maintained a Buy rating on SI-Bone (SIBN – Research Report) yesterday and set a price target of $24.00. The company’s shares closed last Wednesday at $21.44, close to its 52-week high of $23.10. According to
Canaccord Genuity Maintains a Buy Rating on Alphatec Holdings (ATEC)
Canaccord Genuity analyst Kyle Rose maintained a Buy rating on Alphatec Holdings (ATEC – Research Report) yesterday and set a price target of $9.00. The company’s shares closed last Wednesday at $5.89. According to TipRanks.com, Rose is a 4-star analyst
Canaccord Genuity Believes Leaf Group (NYSE: LEAF) Won’t Stop Here
In a report released yesterday, Maria Ripps from Canaccord Genuity maintained a Buy rating on Leaf Group (LEAF – Research Report), with a price target of $7.00. The company’s shares closed last Wednesday at $5.46, close to its 52-week high
